These references help readers distinguish product-specific documents from evidence about hearing health and supplement ingredients more broadly.
Product-specific material
- Supplied product label artwork: our file archive includes the two-blend Supplement Facts image, six-spray usage instructions and distributor contact details. See the transcription and image.
- Seller campaign listing: used for bundle prices and advertised bonuses as of October 11, 2026. Because campaign pages change, our price guide is a dated snapshot.
- Seller support and return terms: vendor support page and published return policy . The vendor controls these documents.
Independent education and literature
- National Institute on Deafness and Other Communication Disorders — Tinnitus : clinical context and limitations of supplement claims.
- NIH Office of Dietary Supplements — What You Need to Know : consumer questions about supplement safety and evidence.
- Soumyanath et al. — analysis of levodopa content in commercial Mucuna supplements : illustrates variability in different products, not a test of NeuroQuiet.
- FDA — Dietary Supplements : U.S. regulation and supplement-label context.
- NIOSH — Noise and hearing safety : public health guidance on noise.
How to interpret the reference list
A paper about Mucuna, for example, should not be interpreted as evidence that NeuroQuiet contains the same studied amounts or has the same clinical outcomes. A vendor policy is evidence of what the seller currently publishes, not a guarantee of what every buyer will experience.
Reviewed: October 11, 2026. Our findings reflect available sources at that time. This site is independent and may earn affiliate commissions.
← Return to NeuroQuiet review